Context Therapeutics has reported encouraging interim Phase 1 data for [...]

Poolbeg Pharma has activated the first clinical site and begun [...]

The Scottish Medicines Consortium (SMC) has accepted TALVEY (talquetamab) for [...]

Mestag Therapeutics has dosed the first patient in its Phase [...]

Mestag Therapeutics has raised $40 million and appointed two senior [...]

The National Institute for Health and Care Excellence (NICE) has [...]

Alys Pharmaceuticals has submitted a clinical trial application (CTA) in [...]